首页> 外国专利> NOVEL PYRIMIDINE SYSTEM DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A MANUFACTURING METHOD THEREOF AND A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) RELATED DISEASE INCLUDING THE SAME AS AN ACTIVE INGREDIENT

NOVEL PYRIMIDINE SYSTEM DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A MANUFACTURING METHOD THEREOF AND A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) RELATED DISEASE INCLUDING THE SAME AS AN ACTIVE INGREDIENT

机译:新型嘧啶系统可衍生出或可药用的盐,其制造方法以及可预防或治疗高级糖基化终产物(残渣)的受体的药物组合物,包括与之相关的有效病因

摘要

PURPOSE: A pyrimidine system derivative compound is provided to be usefully used for the prevention or treatment of dementia, pick disease, Creutzfeldt-Jakob disease, hypothyrodism, Parkinson disease and Huntington disease etc by antagonism against an RAGE receptor.;CONSTITUTION: Pyrimidine system derivatives of a chemical formula 1 or pharmaceutically acceptable salts thereof are provided. A manufacturing method of the pyrimidine system derivatives includes a step of obtaining a compound of a chemical formula 1A by reacting a chloropyrimidine derivative of a chemical formula 2 with a compound of a chemical formula 3. A pharmaceutical composition for the prevention or treatment of RAGE receptor related disease includes the pyrimidine system derivatives of the chemical formula 1 and pharmaceutically acceptable salts thereof as active ingredients.;COPYRIGHT KIPO 2013
机译:目的:提供一种嘧啶系统衍生物,可通过对抗RAGE受体的拮抗作用有效地用于预防或治疗痴呆症,匹克病,克雅氏病,甲状腺功能减退症,帕金森病和亨廷顿病等。;构成:嘧啶系统衍生物提供了化学式1的化合物或其药学上可接受的盐。嘧啶类衍生物的制造方法包括通过使化学式2的氯嘧啶衍生物与化学式3的化合物反应而获得化学式1A的化合物的步骤。一种用于预防或治疗RAGE受体的药物组合物相关疾病包括化学式1的嘧啶系统衍生物及其药学上可接受的盐作为有效成分。; COPYRIGHT KIPO 2013

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号